Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Lynch

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Familial Cancer|July 8, 2017
A new hereditary colorectal cancer network in the Middle East and eastern mediterranean countries to improve care for high-risk familiesZeinab Ghorbanoghli, Carol Jabari, Walid Sweidan, et al.
International Journal of Cancer|July 21, 2005
Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriersAndré Nkondjock, Parviz Ghadirian, Joanne Kotsopoulos, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 4, 2013
Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndromeKaren H Lu, David S Loose, Melinda S Yates, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 15, 2003
Distinguishing right from left colon by the pattern of gene expressionOleg K Glebov, Luz M Rodriguez, Kenneth Nakahara, et al.
The Lancet. Oncology|January 2, 2007
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control studyJohn R McLaughlin, Harvey A Risch, Jan Lubinski, et al.
Genes, Chromosomes & Cancer|June 9, 2005
Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC)Heleen van der Klift, Juul Wijnen, Anja Wagner, et al.
Obstetrics and Gynecology|March 2, 2005
Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndromeKaren H Lu, Mai Dinh, Wendy Kohlmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2009
Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cellsStephen J Salipante, Matthew E Mealiffe, Jeremy Wechsler, et al.
International Journal of Cancer|December 7, 2005
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an updateJacek Gronwald, Nadine Tung, William D Foulkes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2008
Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study GroupKelly A Metcalfe, Jan Lubinski, Parviz Ghadirian, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Familial Cancer|July 8, 2017
A new hereditary colorectal cancer network in the Middle East and eastern mediterranean countries to improve care for high-risk familiesZeinab Ghorbanoghli, Carol Jabari, Walid Sweidan, et al.
International Journal of Cancer|July 21, 2005
Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriersAndré Nkondjock, Parviz Ghadirian, Joanne Kotsopoulos, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 4, 2013
Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndromeKaren H Lu, David S Loose, Melinda S Yates, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 15, 2003
Distinguishing right from left colon by the pattern of gene expressionOleg K Glebov, Luz M Rodriguez, Kenneth Nakahara, et al.
The Lancet. Oncology|January 2, 2007
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control studyJohn R McLaughlin, Harvey A Risch, Jan Lubinski, et al.
Genes, Chromosomes & Cancer|June 9, 2005
Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC)Heleen van der Klift, Juul Wijnen, Anja Wagner, et al.
Obstetrics and Gynecology|March 2, 2005
Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndromeKaren H Lu, Mai Dinh, Wendy Kohlmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2009
Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cellsStephen J Salipante, Matthew E Mealiffe, Jeremy Wechsler, et al.
International Journal of Cancer|December 7, 2005
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an updateJacek Gronwald, Nadine Tung, William D Foulkes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2008
Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study GroupKelly A Metcalfe, Jan Lubinski, Parviz Ghadirian, et al.
Pageof 6